Search Results
Brexucabtagene autoleucel
Brexucabtagene autoleucel is FDA approved for the treatment of
- Adult patients with relapsed or refractory mantle cell lymphoma (MCL).
This indication is approved under accelerated approval based on overall response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. - Adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
MY FIRST 100 DAYS AS LLS PRESIDENT & CEO
Dear Friends,
I’m just over 100 days into my new role as President & CEO of The Leukemia & Lymphoma Society (LLS) and I want to take this moment to say how grateful and proud I am to work alongside all of you in service of blood cancer patients and their families. It’s been great meeting many of you as I travel to our regions and meet with departments throughout the country. And I look forward to meeting many more of you in the months ahead.
Curing AML in Elderly Patients
Robert Hromas, M.D., a blood cancer expert at the University of Florida's College of Medicine, is looking to discover new drugs that will improve the response of elderly AML patients to chemotherapy. His latest research, funded through a Translational Research Program grant from The Leukemia & Lymphoma Society, focuses on inhibiting the DNA repair response.
Supporting Lifesaving Medicaid Expansion for Patients
On November 6, citizens in Idaho, Nebraska, and Utah approved ballot measures to expand Medicaid in their states. These landmark votes will close the coverage gap for more than 360,000 people in these states who earn too much to qualify for traditional Medicaid but not enough to get help with the cost of buying individual coverage.
Shop Online and In-Store at Walgreens to Support LLS
The Leukemia & Lymphoma Society (LLS) and Walgreens are in your corner.
Since 2019, Walgreens has helped to raise more than $30 million for LLS and Susan G. Komen, all with a clear goal in mind: to advance research for tough-to-treat cancers and increase equitable access to care.
IRONMAN World Championships: 5-Star Team Races for Cancer Cures
After months of rigorous training, all five LLS Team In Training teammates finished at the 2017 IRONMAN World Championships in Kona, Hawaii on October 7. The team came together from across the U.S. and Canada to compete in the 140.6 mile iconic triathlon – raising an incredible $435,000 and counting, for blood cancer cures.After months of rigorous training, all five LLS Team In Training teammates finished at the 2017 IRONMAN World Championships in Kona, Hawaii on October 7. The team came together from across the U.S.
Finding Support in Community: Walgreens and LLS Show Up for Blood Cancer Patients
We all need a helping hand sometimes.
Add on a cancer diagnosis and the everyday suddenly feels... different. In many ways, harder.
Ultra-Endurance Athlete Takes on 1000-Mile Iconic Race for Cancer Cures
52-year-old Steve Cannon from Iowa refers to himself as an adventurer, but when you look at his track record of accomplishments, media, spectators and fans across the country refer to him as a beast. He was the first-ever athlete to run around Lake Michigan and averaged a marathon a day for 40 straight days totaling 1,037 miles. He’s also completed a 350-mile bike ride and took on the world’s longest Kayak race – just to list a few.
How Celebrating My 18th Birthday in the Hospital Changed My Perspective
Marlee’s story of courage, inspiration and giving back.
My name is Marlee Pincus and I have cancer. I never in a million years thought I would say those words. Growing up, I never had any medical issues nor a significant family history of cancer. In high school I loved to run, advocate for human rights, and learn Spanish. However, my greatest focus was always on my academics. I graduated Salutatorian of my class and was eager to begin my freshman year at Cornell University.
Ask the Doctor Part 1: Five Questions about Leukemia
Leukemia Survivor, Myrrah Talks to Dr. Nichols about the Latest in Leukemia Research and Treatment
Small Steps Make Big Impact for Moms In Training
Getting the courage to work out is often harder than the workout itself. This is especially true when fitness plans include goals that are hard to measure. Fortunately, through a special partnership with Fitbit, many women in The Leukemia & Lymphoma Society's (LLS) Moms In Training program are learning to better manage their workouts and track their progress.
#ASH18: Beating AML
Sunday marked a significant milestone for The Leukemia & Lymphoma Society (LLS) and the patients we help. Here at the 60th American Society of Hematology (ASH) Annual Meeting in San Diego, a conference attended by more than 30,000 scientists from around the world, we unveiled the first results from our groundbreaking precision medicine Beat AML Master Clinical Trial. To date, more than 356 patients have been screened for this trial.
“Stages” of Leukemia: Understanding Classification and Progression
Table of contents
